Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: May 16, 2016

Total Value ($000): $912,485 (99.4% shares, 0.6% debt)

Holdings (17)

VTI VANGUARD INDEX FDS 32.6%
Value ($000) $297,385 Shares 2,837,100 Est. Cost $57.39 Unrealized
OPHTHOTECH CORP 22.7%
Value ($000) $207,566 Shares 4,910,487 Est. Cost $32.35 Unrealized
INGN INOGEN INC 17.5%
Value ($000) $159,648 Shares 3,549,320 Est. Cost $17.78 Unrealized +100.3%
VGK VANGUARD INTL EQUITY INDEX F 11.2%
Value ($000) $101,941 Shares 2,101,000 Est. Cost $45.01 Unrealized
CRVS CORVUS PHARMACEUTICALS INC 5.0%
Value ($000) $45,734 Shares 3,154,046 Est. Cost $14.35 Unrealized 0.0%
COLUCID PHARMACEUTICALS INC 2.1%
Value ($000) $18,951 Shares 3,056,563 Est. Cost $8.90 Unrealized
TOBIRA THERAPEUTICS INC 2.0%
Value ($000) $18,662 Shares 2,281,405 Est. Cost $17.25 Unrealized
ACCELERON PHARMA INC 1.9%
Value ($000) $17,762 Shares 673,063 Est. Cost $26.39 Unrealized
PEN PENUMBRA, INC. 1.3%
Value ($000) $12,107 Shares 263,191 Est. Cost $43.51 Unrealized +7.4%
NABRIVA THERAPEUTICS AG 0.9%
Value ($000) $7,840 Shares 874,985 Est. Cost $9.50 Unrealized
INVUITY INC 0.7%
Value ($000) $6,759 Shares 936,193 Est. Cost $8.80 Unrealized
WRIGHT MED GROUP N V 0.6%
Value ($000) $5,778 Shares 4,622,032 Est. Cost $1.25 Unrealized
HTG MOLECULAR DIAGNOSTICS INC 0.4%
Value ($000) $3,674 Shares 1,280,185 Est. Cost $11.15 Unrealized
SPECTRANETICS CORP 0.4%
Value ($000) $3,439 Shares 236,826 Est. Cost $14.52 Unrealized
TOKAI PHARMACEUTICALS INC 0.3%
Value ($000) $2,642 Shares 470,946 Est. Cost $14.41 Unrealized
GKOS GLAUKOS CORP 0.2%
Value ($000) $1,705 Shares 101,106 Est. Cost $26.03 Unrealized -33.4%
XENE XENON PHARMACEUTICALS INC 0.1%
Value ($000) $892 Shares 127,563 Est. Cost $14.68 Unrealized -51.0%